PMID- 35979218 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220819 IS - 2296-858X (Print) IS - 2296-858X (Electronic) IS - 2296-858X (Linking) VI - 9 DP - 2022 TI - Case report: Bilateral central serous chorioretinopathy-like abnormalities in a man with pulmonary arterial hypertension. PG - 983548 LID - 10.3389/fmed.2022.983548 [doi] LID - 983548 AB - BACKGROUND: Pulmonary arterial hypertension (PAH) leads to progressive increases in pulmonary vascular resistance, right heart failure, and death if left untreated. Ocular complications secondary to PAH were less reported. In this study, we reported a case of bilateral visual loss and metamorphopsia in a patient with PAH, who developed central serous chorioretinopathy (CSCR)-like abnormalities and optic disc atrophy. CASE SUMMARY: A 45-year-old man presented with decreasing central vision and metamorphopsia in both eyes. He had a history of PAH and 6-year history of low-dose oral sildenafil treatment. Slit-lamp examination revealed prominent dilated and tortuous episcleral and conjunctival vessels. Ultrawide-field color picture showed retinal pigment epithelial mottling and atrophy in ring-like configurations. Ultrawide-field autofluorescence showed multiple irregular hyper-autofluorescence with a constellation-like pattern surrounding the optic nerve head and macular region. Optical coherence tomography angiography (OCTA) b-scan demonstrated CSCR-like changes. Swept-source optical coherence tomography (SS-OCT) analysis showed optic nerve atrophy with enlarged cup/disc ratio in right eye, which was confirmed with perimetry. Fluorescein angiography (FA) showed marked leakage of macula and optic nerve head with time, cystoid macular edema, early blocking with late staining of the flecks as shown in the backgrounds of infrared and autofluorescence, and mild leakage in peripheral retina. Indocyanine green angiography (ICGA) showed dilation, tortuosity and congestion of all vortex veins without obvious leakage. CONCLUSION: Undertreated PAH may cause the congestion of the choroid and induce CSCR-like abnormalities. CI - Copyright (c) 2022 Zhou, Zhang, Gu, Zhou and Zhang. FAU - Zhou, Xinrong AU - Zhou X AD - Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University, Shanghai, China. AD - National Clinical Research Center for Eye Diseases, Shanghai, China. AD - Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China. AD - Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China. AD - Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China. FAU - Zhang, Jingxiang AU - Zhang J AD - Nursing Department, People's Hospital of Huangdao District, Qingdao, China. FAU - Gu, Limin AU - Gu L AD - Department of Ophthalmology, Shanghai Aier Eye Hospital, Shanghai, China. FAU - Zhou, Hao AU - Zhou H AD - Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University, Shanghai, China. AD - National Clinical Research Center for Eye Diseases, Shanghai, China. AD - Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China. AD - Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China. AD - Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China. FAU - Zhang, Jingfa AU - Zhang J AD - Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University, Shanghai, China. AD - National Clinical Research Center for Eye Diseases, Shanghai, China. AD - Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China. AD - Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China. AD - Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, Shanghai, China. LA - eng PT - Case Reports DEP - 20220801 PL - Switzerland TA - Front Med (Lausanne) JT - Frontiers in medicine JID - 101648047 PMC - PMC9376321 OTO - NOTNLM OT - case report OT - central serous chorioretinopathy OT - fundus abnormalities OT - hypertension - complications OT - macular edema OT - pulmonary arterial hypertension OT - vascular disease COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/08/19 06:00 MHDA- 2022/08/19 06:01 PMCR- 2022/08/01 CRDT- 2022/08/18 02:14 PHST- 2022/07/01 00:00 [received] PHST- 2022/07/13 00:00 [accepted] PHST- 2022/08/18 02:14 [entrez] PHST- 2022/08/19 06:00 [pubmed] PHST- 2022/08/19 06:01 [medline] PHST- 2022/08/01 00:00 [pmc-release] AID - 10.3389/fmed.2022.983548 [doi] PST - epublish SO - Front Med (Lausanne). 2022 Aug 1;9:983548. doi: 10.3389/fmed.2022.983548. eCollection 2022.